Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology.
Several clinical trials have recently targeted specific pathways implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, IPF remains plagued by a median survival of 3 yrs and emphasises the need for further research with new insights and perspectives. The prevailing pathogenic hypotheses assume that either an inflammatory process or an independent epithelial/fibroblastic disorder may propagate the disease process. Based on knowledge developed with considerable scientific evidence, we provide our perspectives with an alternative point of view that IPF be considered as a neoproliferative disorder of the lung. Genetic alterations, response to growth and inhibitory signals, resistance to apoptosis, myofibroblast origin and behaviour, altered cellular communications, and intracellular signalling pathways are all fundamental pathogenic hallmarks of both IPF and cancer. The concept of IPF as a lethal malignant disorder of the lung might extend beyond the pathogenic link between these two diseases and disclose new pathogenic mechanisms leading to novel therapeutic options, adopted from cancer biology. Moreover, this vision might dawn the awareness of the public, political and scientific community of this devastating disease from an angle different from the current perception and provoke new ideas and studies to get a better understanding to control the otherwise relentless progressive disease.
Vancheri
C
C
Dept of Internal Medicine and Specialistic Medicine, Section of Respiratory Diseases, University of Catania, Via S. Sofia 78, 95123, 187. 95125, Catania Italy. vancheri@unict.it
Failla
M
M
Crimi
N
N
Raghu
G
G
D018450:Disease Progression; D044127:Epigenesis, Genetic; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology*; D009361:Neoplasm Invasiveness / Q000503:physiopathology; D011230:Precancerous Conditions / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D016019:Survival Analysis